Ullmann, Andrew J <br/><br/>
Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Aug 2006 
 - e29-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/505969  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amphotericin B--adverse effects<br/>Antifungal Agents--adverse effects<br/>Europe<br/>Female<br/>Humans<br/>Immunocompromised Host<br/>Kidney Diseases--chemically induced<br/>Length of Stay<br/>Male<br/>Middle Aged<br/>Mycoses--drug therapy<br/>Polyenes<br/>Prospective Studies